We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of Psoriasis

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00971477
First Posted: September 3, 2009
Last Update Posted: December 13, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of California, Davis
  Purpose

The purpose of this study is to determine if an asynchronous online model of teledermatology can achieve similar clinical outcomes as compared to conventional in-office care for the management of psoriasis. The investigators also aim to determine the effects of this online care model on patient quality of life as well as patient and physician satisfaction.

The investigators' hypotheses include the following:

  1. Compared to in-person visits, the online care model will result in similar clinical improvement in psoriasis disease severity.
  2. Compared to in-person visits, the online care model will result in similar improvements in quality of life.
  3. Providers and subjects in the online group will achieve a similar level of overall satisfaction as those in the in-person group.

Condition Intervention Phase
Psoriasis Other: Online Teledermatology Care Other: Conventional in Office Care Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of Psoriasis

Resource links provided by NLM:


Further study details as provided by University of California, Davis:

Primary Outcome Measures:
  • Psoriasis Area Severity Index (PASI) [ Time Frame: Every 6-8 weeks ]

Enrollment: 64
Study Start Date: August 2009
Study Completion Date: June 2010
Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Teledermatology
Online Telemedicine Group
Other: Online Teledermatology Care
Patients randomized to the intervention group will have their scheduled follow-up visits online via a store and forward teledermatology modality.
Other Name: Health care service modality
Active Comparator: Usual Care
Conventional in-office care
Other: Conventional in Office Care
Patients randomized to the control group will have their scheduled follow-up visits via conventional in office care.
Other Name: Health care service modality

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years of age or older at time of consent, may be men or women.
  • Requiring treatment of psoriasis for medically-indicated reasons.
  • Capable of giving informed consent.
  • Able to have their skin imaged by themselves or by family members.

Exclusion Criteria:

  • Non-English speaking individuals.
  • Individuals lacking access to a digital camera and computer with internet connection.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00971477


Locations
United States, California
UC Davis Department of Dermatology
Sacramento, California, United States, 95816
Sponsors and Collaborators
University of California, Davis
Investigators
Principal Investigator: April W Armstrong, MD UC Davis Department of Dermatology
  More Information

Responsible Party: April W. Armstrong, MD, UC Davis Department of Dermatology
ClinicalTrials.gov Identifier: NCT00971477     History of Changes
Other Study ID Numbers: 2009172431
First Submitted: September 1, 2009
First Posted: September 3, 2009
Last Update Posted: December 13, 2010
Last Verified: December 2010

Keywords provided by University of California, Davis:
Teledermatology
Telemedicine
Psoriasis

Additional relevant MeSH terms:
Psoriasis
Skin Diseases, Papulosquamous
Skin Diseases